Dr. Melissa Morgan, M.D
NPI: 1821071903
Total Payments
$34,294
2024 Payments
$22.05
Companies
40
Transactions
758
Medicare Patients
1,602
Medicare Billing
$116,908
Payment Breakdown by Category
Other$21,050 (61.4%)
Food & Beverage$12,161 (35.5%)
Travel$970.01 (2.8%)
Education$113.00 (0.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $21,050 | 19 | 61.4% |
| Food and Beverage | $12,161 | 723 | 35.5% |
| Travel and Lodging | $970.01 | 7 | 2.8% |
| Education | $113.00 | 9 | 0.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $23,949 | 84 | $0 (2022) |
| Novo Nordisk Inc | $1,969 | 145 | $0 (2021) |
| SANOFI-AVENTIS U.S. LLC | $878.30 | 55 | $0 (2020) |
| Insulet Corporation | $761.05 | 58 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $685.02 | 40 | $0 (2021) |
| Amgen Inc. | $680.90 | 35 | $0 (2021) |
| Lilly USA, LLC | $648.48 | 44 | $0 (2020) |
| Medtronic MiniMed, Inc. | $526.85 | 29 | $0 (2020) |
| Valeritas, Inc. | $479.47 | 19 | $0 (2019) |
| Dexcom, Inc. | $426.02 | 28 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $22.05 | 1 | SANOFI PASTEUR INC. ($22.05) |
| 2023 | $20.52 | 1 | SANOFI PASTEUR INC. ($20.52) |
| 2022 | $4,904 | 6 | AstraZeneca Pharmaceuticals LP ($4,904) |
| 2021 | $9,393 | 30 | AstraZeneca Pharmaceuticals LP ($9,184) |
| 2020 | $9,419 | 91 | AstraZeneca Pharmaceuticals LP ($8,213) |
| 2019 | $4,227 | 214 | AstraZeneca Pharmaceuticals LP ($1,271) |
| 2018 | $3,003 | 209 | Novo Nordisk Inc ($763.86) |
| 2017 | $3,305 | 206 | Novo Nordisk Inc ($571.83) |
All Payment Transactions
758 individual payment records from CMS Open Payments — Page 1 of 31
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/29/2024 | SANOFI PASTEUR INC. | BEYFORTUS (Biological), VAXELIS, MENQUADFI | Food and Beverage | In-kind items and services | $22.05 | General |
| Category: Vaccines | ||||||
| 03/07/2023 | SANOFI PASTEUR INC. | FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological), VAXELIS | Food and Beverage | In-kind items and services | $20.52 | General |
| Category: Vaccines | ||||||
| 07/06/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/30/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $850.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/22/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $297.78 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $146.25 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/17/2022 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $110.06 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,550.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $123.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/04/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $32.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/05/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,700.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/28/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/23/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $111.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/20/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.88 | General |
| Category: DIABETES | ||||||
| 06/30/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,400.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/22/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $317.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $141.12 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $20.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/10/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Travel and Lodging | In-kind items and services | $15.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $100.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/31/2021 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $300.00 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 05/19/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $27.42 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2021 | 5 | 390 | 405 | $59,033 | $14,602 |
| 2020 | 9 | 1,212 | 1,959 | $291,918 | $102,306 |
Total Patients
1,602
Total Services
2,364
Medicare Billing
$116,908
Procedure Codes
14
All Medicare Procedures & Services
14 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 184 | 188 | $48,616 | $10,973 | 22.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 18 | 18 | $6,534 | $1,975 | 30.2% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2021 | 24 | 27 | $1,917 | $703.68 | 36.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 58 | 60 | $1,168 | $582.60 | 49.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 106 | 112 | $798.00 | $367.36 | 46.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 504 | 887 | $192,479 | $68,940 | 35.8% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 97 | 126 | $36,666 | $14,245 | 38.9% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 61 | 61 | $20,130 | $7,337 | 36.4% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 19 | 19 | $7,923 | $3,079 | 38.9% |
| 95251 | Ambulatory continuous glucose (sugar) including interpretation and report for a minimum of 72 hours | Office | 2020 | 47 | 90 | $6,570 | $2,693 | 41.0% |
| 83036 | Hemoglobin a1c level | Office | 2020 | 187 | 268 | $12,596 | $2,589 | 20.6% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2020 | 271 | 481 | $10,101 | $1,570 | 15.5% |
| 10005 | Fine needle aspiration of first lesion using ultrasound guidance | Office | 2020 | 13 | 13 | $3,367 | $1,186 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 13 | 14 | $2,086 | $668.55 | 32.0% |
About Dr. Melissa Morgan, M.D
Dr. Melissa Morgan, M.D is a Endocrinology, Diabetes & Metabolism healthcare provider based in Jacksonville, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/22/2005. The National Provider Identifier (NPI) number assigned to this provider is 1821071903.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Morgan, M.D has received a total of $34,294 in payments from pharmaceutical and medical device companies, with $22.05 received in 2024. These payments were reported across 758 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($21,050).
As a Medicare-enrolled provider, Morgan has provided services to 1,602 Medicare beneficiaries, totaling 2,364 services with total Medicare billing of $116,908. Data is available for 2 years (2020–2021), covering 14 distinct procedure/service records.
Ad
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Jacksonville, FL
- Active Since 11/22/2005
- Last Updated 12/28/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1821071903
Products in Payments
- FARXIGA (Drug) $23,917
- Omnipod (Device) $761.05
- JARDIANCE (Drug) $682.77
- V-GO (Device) $602.57
- Victoza (Drug) $469.01
- TOUJEO (Drug) $429.43
- Minimed 670G System (Device) $415.49
- Ozempic (Drug) $401.25
- AFREZZA (Drug) $366.53
- EVENITY (Biological) $310.32
- JANUVIA (Drug) $295.42
- HUMULIN (Drug) $286.40
- Prolia (Biological) $266.31
- SOLIQUA (Drug) $240.54
- Tresiba (Drug) $202.09
- t-slim insulin pump (Device) $200.28
- Saxenda (Drug) $199.11
- NATPARA (Drug) $187.57
- Dexcom G5 Mobile CGM System (Device) $171.87
- Tymlos (Biological) $169.01
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Jacksonville
Dr. Mae Sheikh-Ali, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.2M
Endocrinology, Diabetes & Metabolism $1.2M
Dr. Wasim Deeb, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $373,299
Endocrinology, Diabetes & Metabolism $373,299
Dr. Senan Sultan, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $199,408
Endocrinology, Diabetes & Metabolism $199,408
Dr. Ricardo Silva, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $65,145
Endocrinology, Diabetes & Metabolism $65,145
Susan Samson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $37,917
Endocrinology, Diabetes & Metabolism $37,917
Dr. Firas Warda, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $24,766
Endocrinology, Diabetes & Metabolism $24,766